News
-
-
-
COMMUNIQUÉ DE PRESSE
EV Nickel Intersects 3 New Zones of Mineralization on the Carlang Trend Including Highest Nickel Grades to Date & Significantly Extends Strike Length by 7km
EV Nickel Inc. announces successful diamond drill program on CarLang Trend confirming near surface nickel mineralization and identifying 3 new zones of large-scale mineralization over 7km of strike -
-
-
COMMUNIQUÉ DE PRESSE
EV Nickel Confirms High-Grade Nickel at Langmuir #2 Intersecting Nickel Grades from 1.07% to 5.11%
EV Nickel Inc. reports high-grade nickel intercepts including 5.11% Ni in Langmuir #2 Nickel Zone, with assay results indicating high nickel tenor. Company plans further drilling to advance Canadian nickel supply chain -
-
-
COMMUNIQUÉ DE PRESSE
Original-Research: APONTIS PHARMA AG (von First Berlin Equity Research GmbH): BUY
First Berlin Equity Research recommends buying APONTIS PHARMA AG shares with a target price of €17 after solid H1/24 results and positive outlook. Analyst Christian Orquera maintains his BUY rating -